IN THE NEWS
Decode taps new precision medicine data-sharing partner
Precision medicine analytics company Decode Health is entering into a data-sharing partnership with data exchange platform Briya.
Decode Health and Quest Diagnostics Joint Research Presented at American Academy of Neurology 2023 Annual Meeting
The American Academy of Neurology (AAN) selected joint research by Decode Health and Quest Diagnostics for presentation at its 2023 Annual Meeting.
Decode Health Selected As 2023 Best In Business Awards Finalist By Nashville Business Journal
Decode Health, a precision medicine analytics company, was recently announced as a 2023 Best in Business Awards finalist by Nashville Business Journal (NBJ).
OUR ABSTRACTS
Development and evaluation of Total RNA sequencing quality controls for blood-based biomarker discovery
November 2023 – Poster Presentation
Application of an advanced data analytics platform leveraging artificial intelligence to identify RNA biomarkers
November 2023 – Poster Presentation
OUR PUBLICATIONS
RECENT PODCASTS
WEBINARS
Next-generation RNA sequencing unlocks the discovery of novel candidate biomarkers for diagnostic and therapeutic applications, but reproducibility is a key challenge in biomarker discovery programs. Integrating multi-faceted quality control (QC) steps can improve design decisions and enhance the confidence and reliability of results. This webinar will demonstrate how a comprehensive QC framework supports a disease-agnostic biomarker discovery program to identify biologically relevant candidate biomarkers of complex disease and how this framework can be adapted for total RNA sequencing of whole blood, plasma, and serum samples.
